Welcome to our dedicated page for Accuray Incorp SEC filings (Ticker: ARAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Accuray’s radiation oncology business is packed with regulatory nuance—each 10-K page covers FDA clearances, global supply chains, and service-contract margins. Finding R&D spend or tracking when executives trade shares should not require hours with spreadsheets. That’s why our SEC filings hub brings Accuray insider trading Form 4 transactions and every other disclosure into one streamlined view.
Stock Titan’s AI reads the fine print for you. Open an Accuray quarterly earnings report 10-Q filing and our algorithms instantly surface backlog changes, CyberKnife unit shipments, and reimbursement commentary. Get Accuray Form 4 insider transactions real-time alerts, side-by-side with revenue trend graphs. Whether you’re understanding Accuray SEC documents with AI for due diligence or need an Accuray annual report 10-K simplified, we translate technical jargon into clear business drivers.
Every filing type is here and searchable: 8-Ks for product-recall updates—see “Accuray 8-K material events explained”—DEF 14A for Accuray proxy statement executive compensation, and of course Form 4 for Accuray executive stock transactions Form 4. Use our AI-powered summaries to compare quarter-over-quarter margin shifts, monitor clinical-trial timelines, and flag warranty reserve changes. With comprehensive coverage, real-time EDGAR pulls, and plain-English insights, you’ll move from document download to actionable perspective in minutes while enjoying Accuray SEC filings explained simply and fast Accuray earnings report filing analysis.
Anne Bryce Le Grand, a director of Accuray Incorporated (ARAY), reported receipt of 78,947 restricted stock units (RSUs) on 08/29/2025. Each RSU represents a contingent right to one share of the issuer's common stock and the award vests 100% on 08/29/2026, resulting in 78,947 shares beneficially owned following the transaction. The filing was signed by Jesse Chew as Power of Attorney for Anne Bryce Le Grand on 09/03/2025. No cash price was paid for the RSUs as reported.
Accuray Inc. (ARAY) has received an amended Schedule 13G filing (Amendment No. 5) from Neuberger Berman Group LLC and Neuberger Berman Investment Advisers LLC. As of 07/31/2025 the Neuberger entities beneficially own 5,242,373 common shares, equal to 4.65 % of Accuray’s outstanding stock. The institutions report shared voting power over 3,991,789 shares and shared dispositive power over the full 5,242,373 shares; they hold no sole voting or dispositive authority. Because the position now falls below the 5 % threshold, Item 5 (“ownership of 5 % or less”) is checked. The filing is made under Rule 13d-1(b), classifying the filers as a parent holding company (HC) and an investment adviser (IA). The signatory, Managing Director Brad Cetron, certifies that the shares were acquired in the ordinary course of business and not to influence control of Accuray.
FAQ
What is the current stock price of Accuray Incorp (ARAY)?
What is the market cap of Accuray Incorp (ARAY)?
